Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Resectable Localized Prostate Cancer × Hydroxychloroquine × Genitourinary × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 5 Carcinoma, Renal Cell 2 Urologic Diseases 1 Resectable Localized Prostate Cancer 1 Prostate Cancer Recurrent 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Nephritis 1 Lung Neoplasms 1 Kidney Diseases 1 Immune System Diseases 1 Glomerulonephritis, IGA 1 Glomerulonephritis 1 Colorectal Neoplasms 1 Carcinoma, Transitional Cell 1 Autoimmune Diseases 1 Adenocarcinoma of Lung 1

Interventions

Hydroxychloroquine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06408298 2026-02-04

HCQ in Resectable Localized Prostate Cancer

Dartmouth-Hitchcock Medical Center

Phase EARLY_PHASE1 Recruiting

Resectable Localized Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡